Literature DB >> 449932

Treatment of advanced endometrial carcinoma with tamoxifen.

K D Swenerton, G W White, D A Boyes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 449932     DOI： 10.1056/NEJM197907123010211

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  Tamoxifen in advanced endometrial carcinoma.

Authors:  J Broens; H T Mouridsen; H M Soerensen
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

Review 2.  Hormonal therapy in advanced or recurrent endometrial cancer.

Authors:  Fani Kokka; Elly Brockbank; David Oram; Chris Gallagher; Andrew Bryant
Journal:  Cochrane Database Syst Rev       Date:  2010-12-08

3.  Phase II study of temsirolimus in women with recurrent or metastatic endometrial cancer: a trial of the NCIC Clinical Trials Group.

Authors:  Amit M Oza; Laurie Elit; Ming-Sound Tsao; Suzanne Kamel-Reid; Jim Biagi; Diane Michele Provencher; Walter H Gotlieb; Paul J Hoskins; Prafull Ghatage; Katia S Tonkin; Helen J Mackay; John Mazurka; Joana Sederias; Percy Ivy; Janet E Dancey; Elizabeth A Eisenhauer
Journal:  J Clin Oncol       Date:  2011-07-25       Impact factor: 44.544

4.  Steroid receptors and human endometrial carcinoma: studies in a nude mouse model.

Authors:  P G Satyaswaroop; R J Zaino; R Mortel
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.